Elizabeth Hoffman, PhD

Dr. Elizabeth Hoffman joined the Division of Extramural Research (DER) at the National Institute on Drug Abuse (NIDA) in 2016 as Scientific Program Manager for the Adolescent Brain Cognitive Development SM (ABCD) Study. In 2023 she was named Associate Director of the ABCD Study®. Dr. Hoffman leads the data sharing program for ABCD, as well as the study’s communication and dissemination efforts. Prior to joining NIDA, Dr. Hoffman conducted functional MRI research on face perception in the Intramural Program at NIMH, taught psychology and cognitive neuroscience, and advocated for science and health policy priorities at the American Psychological Association (APA). Before her tenure at APA, Dr. Hoffman served as a AAAS Fellow and later as a legislative aide on the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee where she had a key role in drafting the Combating Autism Act, a landmark piece of legislation that authorized early screening, education, intervention, and research for autism spectrum disorders, ultimately becoming law. Dr. Hoffman earned a PhD in Cognitive Neuropsychology from the George Washington University and a BA in Psychology and French from Brandeis University.

Funding/Conflicts of Interest: Dr. Elizabeth Hoffman has nothing to disclose.